• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cup

2

The Pentagon said Iran War costs $29 billion, but the real cost is closer to $200 billion—and counting

3

Amazon's record Prime Day masks a darker truth: Americans are spending more and getting less

1

After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cup

2

The Pentagon said Iran War costs $29 billion, but the real cost is closer to $200 billion—and counting

3

Amazon's record Prime Day masks a darker truth: Americans are spending more and getting less
Health

Top Chinese virologist slams China’s ‘COVID Zero’ policy in rare sign of domestic dissent

By
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Bloomberg
Bloomberg
Down Arrow Button Icon
November 10, 2021, 7:21 AM ET
Add Fortune on Google for similar content.

A top Chinese virologist warned the country risks economic collapse if local officials continue to try to wipe out all traces of COVID-19, marking the most vocal criticism of China’s so-called COVID Zero approach by one of its own experts.

Guan Yi, a virologist at the University of Hong Kong, disparaged China’s effort to eliminate sporadic flareups of the virus through mass testing and lengthy quarantines. In the wide-ranging interview with Hong Kong-based Phoenix Satellite TV, he urged a reality-check on how well an extensive vaccination drive helped the world’s most populous country build immunity to COVID. 

“We don’t stand a chance if we pursue a target of zero COVID,” said Guan, who’s been dubbed the “virus hunter” by the Chinese media for his work on identifying the animal origins of the coronaviruses that caused SARS and MERS. “The virus is here today, just like flu. That’s a fact, whether people like it or not.”

The ability to break away from COVID Zero hinges on the effectiveness of the vaccines and the cost of controlling the virus, Guan said. It’s crucial for China to figure out how much protection its mass vaccination program has afforded the population, he said.

“Let’s not roll out nucleic acid testing for everyone at every turn,” he said. “I think it’s testing antibodies that matters. Everybody should know where their immunity is at.”

Guan’s comments are a rare, high-profile criticism from within the country’s elite of its lingering adherence to COVID Zero, which other adherents like Singapore and Australia have abandoned as the more transmissible delta variant makes it almost impossible to maintain. The criticism follows on the heels of an emotional plea for support made by the former vice mayor of a border town called Ruili in southwestern China, where repetitive lockdowns after COVID incursions from Myanmar are threatening livelihoods and exhausting local officials.

Officials in China have said they still consider squashing domestic flareups with aggressive curbs a better option for people’s safety and the economy’s health than reopening borders and easing restrictions. The country will maintain stringent curbs at least through spring given the outbreaks beyond its borders, health officials said in Beijing on Saturday. 

It’s also doubling-down on vaccinations. More than 75% of the country is fully protected and authorities are rolling out booster shots to all adults. Immunizations are now available to children as young as three years old. 

Still, Guan questioned the impact of vaccination in China when local governments won’t relent on controls such as quarantine and temperature screening. While taking temperatures is ubiquitous across the country, the virologist said that’s a “lagging defense” because infected people can spread the virus without showing any symptoms. 

“Don’t blame the virus for being stealthy,” he said. “We just consider ourselves smarter than we really are.” 

Instead, Guan said the country must develop a clearer understanding about how the homegrown vaccines are working against new variants of the virus. It should “kick out vaccines that have become ineffective,” he said. 

China’s leading shots, from state-backed Sinopharm and Sinovac Biotech Ltd., use traditional vaccine technology. While clinical trials show them to be effective at preventing severe cases of COVID, hospitalizations and deaths, they are less reliable than Western mRNA shots at stopping transmission and reducing overall case counts. 

“One can tell what’s good or bad through comparison,” Guan said. “If we fail to recognize our shortcomings, we lack the incentive to make progress.”

More health care and Big Pharma coverage from Fortune:

  • Biden’s vaccine mandate may be tied up in court—but employers shouldn’t wait to enforce it, say legal experts
  • State Farm publicly supports NFL’s Aaron Rodgers after his vaccine comments—while quietly removing most of his ads
  • How Big Bird became the unlikely target of GOP senators
  • Denmark ditched its COVID rules 2 months ago. Now cases are up—and restrictions are coming back
  • Air purifiers and CO2 monitors are the new pencil and paper in classrooms

Subscribe to Fortune Daily to get essential business stories straight to your inbox each morning.

About the Author
By Bloomberg
See full bioRight Arrow Button Icon
Add Fortune on Google for similar content.

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

How ‘Ozempic face’ is pushing Gen X, already the biggest Botox and filler consumers, to the facelift table a decade early
HealthGen X
How ‘Ozempic face’ is pushing Gen X, already the biggest Botox and filler consumers, to the facelift table a decade early
By Mia OsmonbekovJune 24, 2026
2 hours ago
The 4 Best Zinc Supplements of 2026: Expert Tested
HealthDietary Supplements
The 4 Best Zinc Supplements of 2026: Expert Tested
By Emily PharesJune 24, 2026
3 hours ago
Helix Plus Lead
Healthmattresses
The Best Early 4th of July Mattress Sales of 2026: Saatva, Helix, and More
By Christina SnyderJune 24, 2026
5 hours ago
mg
CommentaryHealth
The ‘tech neck’ time bomb: why 43 million young Americans could cripple U.S. health care within a generation
By Michael GerlingJune 24, 2026
11 hours ago
UPS workers process boxes in a sorting facility.
North AmericaUPS
UPS is shelling out nearly $50 million on temperature-controlled facilities to meet the booming demand for GLP-1 deliveries
By Sasha RogelbergJune 23, 2026
1 day ago
dr
HealthCancer
The U.S. cut cancer deaths by 34% since 1991—but not in 458 rural counties
By Arthur Cosby and The ConversationJune 23, 2026
1 day ago

Most Popular

After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cup
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cup
By Orianna Rosa RoyleJune 23, 2026
1 day ago
The Pentagon said Iran War costs $29 billion, but the real cost is closer to $200 billion—and counting
Economy
The Pentagon said Iran War costs $29 billion, but the real cost is closer to $200 billion—and counting
By Jacqueline MunisJune 24, 2026
16 hours ago
Amazon's record Prime Day masks a darker truth: Americans are spending more and getting less
Retail
Amazon's record Prime Day masks a darker truth: Americans are spending more and getting less
By Nick LichtenbergJune 24, 2026
8 hours ago
Ray Dalio just finished a 10-day trip to China. He says global leaders know America 'doesn’t have what it takes to fight to maintain its empire'
Asia
Ray Dalio just finished a 10-day trip to China. He says global leaders know America 'doesn’t have what it takes to fight to maintain its empire'
By Nick LichtenbergJune 24, 2026
10 hours ago
Current price of oil as of June 23, 2026
Personal Finance
Current price of oil as of June 23, 2026
By Joseph HostetlerJune 23, 2026
1 day ago
Current price of gold as of June 23, 2026
Personal Finance
Current price of gold as of June 23, 2026
By Danny BakstJune 23, 2026
1 day ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.